Mechthild Krause

14.9k total citations · 3 hit papers
252 papers, 8.8k citations indexed

About

Mechthild Krause is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mechthild Krause has authored 252 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Pulmonary and Respiratory Medicine, 84 papers in Oncology and 83 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mechthild Krause's work include Advanced Radiotherapy Techniques (56 papers), Radiation Therapy and Dosimetry (53 papers) and Medical Imaging Techniques and Applications (39 papers). Mechthild Krause is often cited by papers focused on Advanced Radiotherapy Techniques (56 papers), Radiation Therapy and Dosimetry (53 papers) and Medical Imaging Techniques and Applications (39 papers). Mechthild Krause collaborates with scholars based in Germany, United States and Netherlands. Mechthild Krause's co-authors include Michaël Baumann, Daniel Zips, Rićhard P. Hill, Christian Richter, Ala Yaromina, Howard D. Thames, Wolfgang Eicheler, Steffen Löck, Cläre von Neubeck and Esther G.C. Troost and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Mechthild Krause

241 papers receiving 8.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exploring the role of cancer stem cells in radioresistance

2008 661 citations Michaël Baumann, Mechthild Krause et al. profile →
Radiation oncology in the era of precision medicine

2016 567 citations Michaël Baumann, Mechthild Krause et al. profile →
ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer

2015 485 citations Mechthild Krause et al. Radiotherapy and Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mechthild Krause Germany	49	3.5k	3.1k	2.5k	2.4k	2.4k	252	8.8k
Daniel Zips Germany	42	2.5k 0.7×	1.8k 0.6×	1.6k 0.6×	2.6k 1.1×	1.9k 0.8×	310	6.9k
Peter E. Huber Germany	59	3.1k 0.9×	3.0k 1.0×	3.0k 1.2×	2.4k 1.0×	1.5k 0.6×	265	11.5k
Johannes H.A.M. Kaanders Netherlands	50	2.2k 0.6×	1.7k 0.6×	1.9k 0.8×	2.3k 0.9×	2.5k 1.0×	177	7.4k
Michael Milosevic Canada	62	3.6k 1.0×	2.1k 0.7×	2.2k 0.9×	3.8k 1.6×	2.4k 1.0×	312	12.3k
Albert J. van der Kogel Netherlands	53	2.1k 0.6×	1.2k 0.4×	2.4k 0.9×	2.6k 1.0×	3.0k 1.3×	140	8.2k
Jason A. Koutcher United States	55	3.8k 1.1×	2.3k 0.7×	4.9k 1.9×	4.7k 1.9×	2.3k 1.0×	233	13.0k
Edward E. Graves United States	45	1.9k 0.6×	1.3k 0.4×	1.6k 0.7×	3.2k 1.3×	1.1k 0.5×	174	7.2k
Bin S. Teh United States	48	4.0k 1.2×	2.0k 0.6×	1.2k 0.5×	1.6k 0.6×	1.1k 0.4×	374	8.4k
Rolf Lewensohn Sweden	42	2.3k 0.7×	2.0k 0.6×	3.1k 1.3×	962 0.4×	1.3k 0.5×	223	7.1k
John L. Humm United States	68	5.7k 1.7×	2.3k 0.7×	2.1k 0.8×	10.5k 4.3×	2.3k 1.0×	294	15.5k

Countries citing papers authored by Mechthild Krause

Since Specialization

Citations

This map shows the geographic impact of Mechthild Krause's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mechthild Krause with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mechthild Krause more than expected).

Fields of papers citing papers by Mechthild Krause

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mechthild Krause. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mechthild Krause. The network helps show where Mechthild Krause may publish in the future.

Co-authorship network of co-authors of Mechthild Krause

This figure shows the co-authorship network connecting the top 25 collaborators of Mechthild Krause. A scholar is included among the top collaborators of Mechthild Krause based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mechthild Krause. Mechthild Krause is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lühr, Armin, Rebecca Bütof, Annekatrin Seidlitz, et al.. (2025). Model validation confirms variable relative biological effectiveness and elevated periventricular sensitivity after proton therapy of brain tumors. Radiotherapy and Oncology. 214. 111271–111271.

Troost, Esther G.C., Mechthild Krause, Christian Hahn, et al.. (2024). A deep-learning-based surrogate model for Monte-Carlo simulations of the linear energy transfer in primary brain tumor patients treated with proton-beam radiotherapy. Physics in Medicine and Biology. 69(16). 165034–165034. 1 indexed citations

Richter, Susan, Steffen Löck, Annett Linge, et al.. (2024). Epigenetic Targeting to Overcome Radioresistance in Head and Neck Cancer. Cancers. 16(4). 730–730. 6 indexed citations

Hölscher, Tobias, Michaël Baumann, Jörg Kotzerke, et al.. (2022). Local Control after Locally Ablative, Image-Guided Radiotherapy of Oligometastases Identified by Gallium-68-PSMA-Positron Emission Tomography in Castration-Sensitive Prostate Cancer Patients (OLI-P). Cancers. 14(9). 2073–2073. 4 indexed citations

Poleszczuk, Jan, Susan Richter, Mirko Peitzsch, et al.. (2022). Cellular plasticity upon proton irradiation determines tumor cell radiosensitivity. Cell Reports. 38(8). 110422–110422. 12 indexed citations

Löck, Steffen, Kristin Gurtner, Ala Yaromina, et al.. (2021). Value of functional in-vivo endpoints in preclinical radiation research. Radiotherapy and Oncology. 158. 155–161. 5 indexed citations

Seidlitz, Annekatrin, Bettina Beuthien‐Baumann, Steffen Löck, et al.. (2020). Final Results of the Prospective Biomarker Trial PETra: [11C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma. Clinical Cancer Research. 27(5). 1351–1360. 14 indexed citations

Löck, Steffen, Volker Gudziol, Sandra Hering, et al.. (2019). Residual gammaH2AX foci in head and neck squamous cell carcinomas as predictors for tumour radiosensitivity: Evaluation in pre-clinical xenograft models and clinical specimens. Radiotherapy and Oncology. 137. 24–31. 14 indexed citations

Lutz, B., Patrick Wohlfahrt, W. Enghardt, et al.. (2019). A Monte Carlo based radiation response modelling framework to assess variability of clinical RBE in proton therapy. Physics in Medicine and Biology. 64(22). 225020–225020. 25 indexed citations

10.

Bandurska‐Luque, Anna, Steffen Löck, Robert Haase, et al.. (2018). FMISO-PET-based lymph node hypoxia adds to the prognostic value of tumor only hypoxia in HNSCC patients. Radiotherapy and Oncology. 130. 97–103. 15 indexed citations

11.

Han, Jing, Lynnette Marcar, Joshua C. Black, et al.. (2017). Radiation Resistance in KRAS-Mutated Lung Cancer Is Enabled by Stem-like Properties Mediated by an Osteopontin–EGFR Pathway. Cancer Research. 77(8). 2018–2028. 77 indexed citations

12.

Lühr, Armin, Cläre von Neubeck, Max Peter Baumann, Mechthild Krause, & W. Enghardt. (2017). OC-0244: Does the RBE depend on ion type?. Radiotherapy and Oncology. 123. S123–S123. 1 indexed citations

13.

Peitzsch, Claudia, Monica Cojoc, Ina Kurth, et al.. (2016). An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells. Cancer Research. 76(9). 2637–2651. 57 indexed citations

14.

Cojoc, Monica, Claudia Peitzsch, Ina Kurth, et al.. (2015). Aldehyde Dehydrogenase Is Regulated by β-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells. Cancer Research. 75(7). 1482–1494. 187 indexed citations

15.

Zschaeck, Sebastian, Robert Haase, Nasreddin Abolmaali, et al.. (2015). Spatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure. Acta Oncologica. 54(9). 1355–1363. 48 indexed citations

16.

Wang, Meng, Patricia Greninger, Anurag Singh, et al.. (2014). EGFR-Mediated Chromatin Condensation Protects KRAS-Mutant Cancer Cells against Ionizing Radiation. Cancer Research. 74(10). 2825–2834. 55 indexed citations

17.

Brüchner, Kerstin, et al.. (2014). Establishment of a small animal tumour model for in vivo studies with low energy laser accelerated particles. Radiation Oncology. 9(1). 57–57. 18 indexed citations

18.

Eke, Iris, Katja Storch, Mechthild Krause, & Nils Cordes. (2013). Cetuximab Attenuates Its Cytotoxic and Radiosensitizing Potential by Inducing Fibronectin Biosynthesis. Cancer Research. 73(19). 5869–5879. 48 indexed citations

19.

Wang, Meng, David M. Sander, Liliana Gheorghiu, et al.. (2011). EGF Receptor Inhibition Radiosensitizes NSCLC Cells by Inducing Senescence in Cells Sustaining DNA Double-Strand Breaks. Cancer Research. 71(19). 6261–6269. 96 indexed citations

20.

Storch, Katja, Iris Eke, Kerstin Borgmann, et al.. (2010). Three-Dimensional Cell Growth Confers Radioresistance by Chromatin Density Modification. Cancer Research. 70(10). 3925–3934. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact